The Asia Pacific respiratory care devices market is expected to grow from US$ 4,543.26 million in 2022 to US$ 8,089.96 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2022 to 2028.
Medical device research and development are considered highly capital-intensive and fraught with enormous risks. A thriving R&D ecosystem becomes the perfect nurturing ground for developing competitive and top-of-the-line products, from conceiving an ideal product design to new product development, prototyping, validation, and testing. To produce innovative products, MedTech companies are investing a huge part of revenue in R&D. For instance, in 2021, ResMed invested US$ 225.3 million in research and development activities, representing 7.0% of their net revenues from 2021 and 12% from 2020. With a continued focus on developing and commercializing new, innovative products and solutions, the company aims to improve patient outcomes, help physicians and providers better manage chronic diseases, and lower healthcare costs. In May 2021, Sanichi Technology Bhd completed its research and development phase for medical-grade mechanical air ventilators, slated to be distributed to local and overseas healthcare markets. In September 2019, Koninklijke Philips N.V. launched Philips Night Balance, a prescription sleep position therapy device designed for patients suffering from positional OSA. The product is likely a non-inferior treatment to continuous positive airway pressure (CPAP) and demonstrates high adherence rates among positional OSA patients. Further, the medical device industry is poised for steady growth. The rising needs for respiratory care devices reflect increasing demand for innovative devices, including wearables and services (health data). Respiratory care device manufacturers are aiming to increase the ventilator production to potentially avoid the looming shortage and the possible need to ration respiratory devices. For instance, Zoll Medical announced producing 10,000 ventilators per month in response to the COVID-19 pandemic. This represents a 25-fold increase in its production volume, and it is prepared to expand its supply base as necessary. Other efforts include a collaboration between device maker Ventec Life Systems and GM to develop its ventilator production. ResMed announced its goal to double or triple ventilator output and scale-up ventilation mask production more than 10-fold. Thus, the research and development in medical device initiates the growth in the market.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the respiratory care devices market growth at a notable CAGR during the forecast period.
Asia Pacific Respiratory Care Devices Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Respiratory Care Devices Market Segmentation
The market for Asia Pacific respiratory care devices market is segmented into product, indication, end user and country. Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. The market for the therapeutics devices segment is sub segmented into positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, and others. The market for the monitoring device segment is sub segmented into pulse oximeters, scenography, and gas analyzers. The market for the diagnostic devices segment is further segmented into spirometers, polysomnography devices, peak flow meters, and other diagnostic devices. The market for the consumables & accessories segment is sub segmented into masks, disposable resuscitators, tracheostomy tubes, breathing circuits, and other consumables and accessories. By indication, the market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Based on end user, the Asia Pacific respiratory care devices market is divided into hospitals, home care, and ambulatory care. Based on country, the Asia Pacific respiratory care devices market is segmented into the China, India, Japan, Australia, South Korea and Rest of Asia Pacific.
Asia Pacific Respiratory Care Devices Market—Companies Mentioned
Koninklijke Philips N.V.; ResMed Inc.; Medtronic; Masimo; THERMO FISHER SCIENTIFIC INC; Dragerwerk AG & Co. KGaA; Invacare Corporation; Getinge AB.; Nihon Kohden Corporation; Air Liquide; and Teleflex Incorporated are a few major companies operating in the Asia Pacific respiratory care devices market.